News

Drugs developed to treat AIDS and HIV could offer hope to patients diagnosed with meningioma and acoustic neuroma brain tumors.

A new approach could help to reduce a serious adverse effect related to chimeric antigen receptor (CAR) T-cell therapy.

Researchers have demonstrated how healthy epithelial cells recognize precancerous ones and the mechanism behind their eventual elimination.

Researchers have tested various treatment approaches to determine how effective they are in combatting certain types of cancer.

According to researchers using computer modeling and cell studies, more patients may be helped by a common class of targeted therapies than previously thought.

AI models that evaluate medical images could speed up and improve the accuracy of cancer diagnoses, but they may be vulnerable to cyberattacks. In a study, researchers simulated an attack that falsified mammogram images, fooling both an AI breast cancer diagnosis model and human breast imaging experts.

A Phase 2 clinical trial has shown that using sotorasib as a monotherapy can shrink tumors for patients who have KRAS^G12C-mutated colorectal tumors

A new trial has identified a combination of five existing drugs that keeps cancer at bay for longer in patients with highly aggressive bone marrow cancer.

Scientists from The Institute of Cancer Research are collaborating with the Cambridge-based immuno-oncology company Crescendo Biologics to develop a potential "next-generation" immunotherapy.

Lung cancer is usually diagnosed at a late stage when the survival rate is extremely low, as the current method for early lung cancer detection isn’t feasible as a widespread test. A new study provides proof-of-concept for the ability of a drop of blood to reveal lung cancer in asymptomatic patients.